These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 8078414

  • 21. Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
    de Sá Del Fiol F, Rocha De Mattos Filho T, Groppo FC.
    Braz J Infect Dis; 2000 Feb; 4(1):36-42. PubMed ID: 10788844
    [Abstract] [Full Text] [Related]

  • 22. Structural aspects for evolution of beta-lactamases from penicillin-binding proteins.
    Meroueh SO, Minasov G, Lee W, Shoichet BK, Mobashery S.
    J Am Chem Soc; 2003 Aug 13; 125(32):9612-8. PubMed ID: 12904027
    [Abstract] [Full Text] [Related]

  • 23. Crystal structure of extended-spectrum beta-lactamase Toho-1: insights into the molecular mechanism for catalytic reaction and substrate specificity expansion.
    Ibuka AS, Ishii Y, Galleni M, Ishiguro M, Yamaguchi K, Frère JM, Matsuzawa H, Sakai H.
    Biochemistry; 2003 Sep 16; 42(36):10634-43. PubMed ID: 12962487
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Biochemical Characterization of SFC-1, a class A carbapenem-hydrolyzing beta-lactamase.
    Fonseca F, Sarmento AC, Henriques I, Samyn B, van Beeumen J, Domingues P, Domingues MR, Saavedra MJ, Correia A.
    Antimicrob Agents Chemother; 2007 Dec 16; 51(12):4512-4. PubMed ID: 17875998
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. An engineered disulfide bond between residues 69 and 238 in extended-spectrum beta-lactamase Toho-1 reduces its activity toward third-generation cephalosporins.
    Shimizu-Ibuka A, Matsuzawa H, Sakai H.
    Biochemistry; 2004 Dec 21; 43(50):15737-45. PubMed ID: 15595829
    [Abstract] [Full Text] [Related]

  • 28. Fluorophore-labeled beta-lactamase as a biosensor for beta-lactam antibiotics: a study of the biosensing process.
    Chan PH, So PK, Ma DL, Zhao Y, Lai TS, Chung WH, Chan KC, Yiu KF, Chan HW, Siu FM, Tsang CW, Leung YC, Wong KY.
    J Am Chem Soc; 2008 May 21; 130(20):6351-61. PubMed ID: 18429614
    [Abstract] [Full Text] [Related]

  • 29. Kinetic interactions of tazobactam with beta-lactamases from all major structural classes.
    Bush K, Macalintal C, Rasmussen BA, Lee VJ, Yang Y.
    Antimicrob Agents Chemother; 1993 Apr 21; 37(4):851-8. PubMed ID: 8388201
    [Abstract] [Full Text] [Related]

  • 30. [Beta-lactamase inhibitors. I. Synthesis and biological properties of penicillanic acid derivatives].
    Mikołajczyk J, Kotulowa W, Kazimierczak J, Sikora A, Rogowska W, Cieślak J.
    Acta Pol Pharm; 1980 Apr 21; 37(6):637-41. PubMed ID: 6270960
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Comparative study of the properties of plasmid mediated staphylococcal beta-lactamase as expressed in Escherichia coli.
    Saha D, Bal M.
    Biochem Mol Biol Int; 1993 Jan 21; 29(1):149-59. PubMed ID: 8490561
    [Abstract] [Full Text] [Related]

  • 33. Mechanism of inhibition of the class A beta -lactamases PC1 and TEM-1 by tazobactam. Observation of reaction products by electrospray ionization mass spectrometry.
    Yang Y, Janota K, Tabei K, Huang N, Siegel MM, Lin YI, Rasmussen BA, Shlaes DM.
    J Biol Chem; 2000 Sep 01; 275(35):26674-82. PubMed ID: 10837472
    [Abstract] [Full Text] [Related]

  • 34. Interaction between class B beta-lactamases and suicide substrates of active-site serine beta-lactamases.
    Prosperi-Meys C, Llabres G, de Seny D, Soto RP, Valladares MH, Laraki N, Frere JM, Galleni M.
    FEBS Lett; 1999 Jan 25; 443(2):109-11. PubMed ID: 9989585
    [Abstract] [Full Text] [Related]

  • 35. Identification of the site of covalent attachment of nafcillin, a reversible suicide inhibitor of beta-lactamase.
    Tan AK, Fink AL.
    Biochem J; 1992 Jan 01; 281 ( Pt 1)(Pt 1):191-6. PubMed ID: 1731755
    [Abstract] [Full Text] [Related]

  • 36. Inhibition of the SHV-1 beta-lactamase by sulfones: crystallographic observation of two reaction intermediates with tazobactam.
    Kuzin AP, Nukaga M, Nukaga Y, Hujer A, Bonomo RA, Knox JR.
    Biochemistry; 2001 Feb 13; 40(6):1861-6. PubMed ID: 11327849
    [Abstract] [Full Text] [Related]

  • 37. Beta-lactamases as fully efficient enzymes. Determination of all the rate constants in the acyl-enzyme mechanism.
    Christensen H, Martin MT, Waley SG.
    Biochem J; 1990 Mar 15; 266(3):853-61. PubMed ID: 2158301
    [Abstract] [Full Text] [Related]

  • 38. Inactivation of CMY-2 beta-lactamase by tazobactam: initial mass spectroscopic characterization.
    Bonomo RA, Liu J, Chen Y, Ng L, Hujer AM, Anderson VE.
    Biochim Biophys Acta; 2001 Jun 11; 1547(2):196-205. PubMed ID: 11410275
    [Abstract] [Full Text] [Related]

  • 39. Efficient catalysis by beta-lactamase from Staphylococcus aureus PC1 accompanied by accumulation of an acyl-enzyme.
    Qi X, Virden R.
    Biochem J; 1996 Apr 15; 315 ( Pt 2)(Pt 2):537-41. PubMed ID: 8615826
    [Abstract] [Full Text] [Related]

  • 40. Rational design of a beta-lactamase inhibitor achieved via stabilization of the trans-enamine intermediate: 1.28 A crystal structure of wt SHV-1 complex with a penam sulfone.
    Padayatti PS, Sheri A, Totir MA, Helfand MS, Carey MP, Anderson VE, Carey PR, Bethel CR, Bonomo RA, Buynak JD, van den Akker F.
    J Am Chem Soc; 2006 Oct 11; 128(40):13235-42. PubMed ID: 17017804
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.